chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A nurse reported that a child received an injection of Prevnar and within 24 hours, post vax, developed a fever of 103F to 104F. No further information was available at the date of this report. The reporter indicated that 5 pts experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided. In addition, 1 of the lot numbers was reported as 47653; however, this is not a valid Lederle lot number. This is 1 of 2 reports from this facility of adverse experiences following receipt of Prevnar.
Approximately 2"x2" irregularly-shaped redness at injection site. Has been warm to the touch at times. Redness appeared to lighten on 01/25/2021, but was darker and itchy on 1/26/2021.
The adverse event began late in the evening on the day of the vaccination (4/11/2021) . The patient experienced heart palpitations / racing heart / extremely elevated pulse. Throughout the night, starting at 11PM, whenever the patient would stand up, her pulse would rise to 160-170bpm. There was slight improvement the following morning (4/12/2021), but the pulse has still been higher than normal. On day 2 following the vaccine (4/13/21), there is even more improvement, but the pulse is still higher than normal.
Raised area appeared on his arm. Not sure if it would be described as a nodule or growth
Per patient, she has been experiencing pain starting from her shoulder to her pinky and ring finger .  The pain is deep and started around the same time that she got her Pfizer Covid Vaccine.  She doesn't know whether or not the vaccine is causing the pain, but since the pain present around the same time, she is relating it to the vaccine as the possible cause.  The pain initially come and go but in recent weeks has been constant.  Nothing help with the pain, moving her arm around or taking ibuprofen 800mg.
Pain in my arm (right side) has never stopped hurting every AM when I wake there is limited motion and stiffness, burning sensations in my arm, lack of energy to the point of weakness. I was sicker than heck all of Nov, Dec / body pain. I've had a MRI of my arm and I had to wear a heart monitor for 21 day to make sure it was just my heart acting up. On Sept 13, 2016, I received the FLUZONE vaccine. After a week or two I noticed that my right arm was still hurting at the injection site and that I had a knot or lump under the skin. I knew this wasn't normal because I had gotten a flu shot every year for over 12 years and never had any issues. I used a muscle pain cream on the area but that only gave me an hour or so of relief. I called my primary care and reported the issue. All of Nov and Dec 2016 I wasn't feeling well at all I dealt with very painful body aches, weakness, loss of appetite to present, lack of energy. On Jan 24, 2017, I had a routine visit with my Cardiologist I told him about the lack of energy, shortness of breath, he in turn ordered me to wear a heart monitor for 21 days because I'm Afib. The results came back showing my heart was not making me feel ill. On Jan 31, 2017, I went to a Infectious Disease Specialists and also that same day I had a MRI done on my arm. Every morning my right arm is very stiff and painful from my shoulder to elbow with limited range of motion.
Dermatographia started about 11-12 days after vaccination and continued for 3-4 months after vaccination. Improved with steroids and prolonged course of cetirizine.
Pt. had 2 episodes of "staring off at nothing" lasting several seconds. Also apperently had "hand tremor" episode X2 of a few seconds duration.
This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a female patient who received SHINGRIX for prophylaxis. On 15th August 2018, the patient received SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site pain, injection site erythema, injection site warmth and pain in joint involving shoulder region. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site pain, injection site erythema and injection site warmth were recovered/resolved and the outcome of the pain in joint involving shoulder region was not recovered/not resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site pain, injection site erythema, injection site warmth and pain in joint involving shoulder region to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient could not remember if that same day of vaccination or the day after she started having pain at the site of the injection. It was pain, redness, heat and swelling at the injection site. The patient described it as having a greater around her arm at the site of injection that spread five inches wide around her arm radiating heat, swelling and redness. The patient said that less than a year after receiving SHINGRIX, she was still experiencing pain in her upper arm, where the shoulder joins the body (not the injection site). The patient had that pain any time she moves her arm around.
1st episode and shingles (R) frank. (under breast age 60.) Pt. given ZOSTAVAX 2011. Pt now 11/7/13 with clinical zoster under (R) breast --> frank.
This spontaneous report as received from a other health professional (Registered nurse) refers to unspecified number of patients of unknown age. Current conditions and medical history was not reported. On an unknown date in 2014 (reported as since September 2014) the patients were vaccinated with ZOSTAVAX for an unknown indication (dose, route, lot number and frequency were not reported). Concomitant medications were not reported. Since September 2014, the patients were administered improperly stored ZOSTAVAX. No adverse effects were noted. Outcome and causality assessment was not reported. Product quality complaint was not reported. No additional information reported. This is one of several reports received from the same reporter. Additional information has been requested.
Administered after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a adult female patient who received Herpes zoster (Shingrix) (batch number LG3B4, expiry date 8th April 2023) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 12-Aug-2022 Reporter's comment: The medical assistant stating that refrigerator temperature log indicated out of range temperatures for Shingrix.   The lowest recorded was 3.7 degrees Celsius and the highest was 9.2 degrees Celsius on 7th August 2022 (for 48 minutes).   This case is for 7 out of 10 linked patients reported by same reporter. Additional supportive information: The patient received Shingrix after temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2022118568:Same reporter. US-GSK-US2022118569:Same reporter. US-GSK-US2022118570:Same reporter. US-GSK-US2022118571:Same reporter. US-GSK-US2022118616:Same reporter US-GSK-US2022118615:Same reporter US-GSK-US2022118614:Same reporter US-GSK-US2022118613:Same reporter US-GSK-US2022118612:Same reporter
patient felt funny after shot. EMS was called vitals were taken BP 194/114  BG 143 HR 93. Cardiac Rhythm Disturbance but patient refused additional evaluation and care.  Released against medical advice.
This spontaneous report as received from a pharmacist refers to a 67 year old male patient. The patient's medical history included a drug reaction/allergy to DARVON. On 18-MAR-2014, the patient was vaccinated with ZOSTAVAX lot # J011339, 0.65 ml, subcutaneous. Concomitant therapies included finasteride. On an unknown date in March 2014 after receiving ZOSTAVAX, the patient experienced shingles. The patient visited the physician due to the adverse event. The patient received no treatment for the shingles. The physician asked the pharmacist if the patient could receive VALTREX. The outcome of the shingles is unknown. A causality assessment was not provided. Additional information has been requested.
My period is very regular, every 28-29 days. It always has been. I had a period start on 4/1/21, then totally missed a period that should have started 4/29/21, then I started one on 5/30/21 and I have been bleeding for 16 days straight. It is very heavy, and I am passing big clots. It looks like a tablespoon (or sometimes bigger) and it looks like dark red jelly. I can feel it moving before it plops out. I haven't experienced this type of clots since I first had babies (since more than 26 years ago.)
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 08-NOV-2016, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX, 0.5 ml, lot # M023380, expiry date 11-MAY-2018 (dose, route and site of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 36 degrees Fahrenheit 43 days. There was no previous temperature excursion. Data logger was not involved. Additional information has been requested.
Vomiting and blotching of palms. Redness noted on feet and in face. At 15:00, doing well. At 17:00, resting.
Sweating, severe shaking, coughing, nausea, near fainting, severe tightening of chest.
10/22/09 SITE SWELLED ; AT INJECTION SITE "KNOT FORMED"; ELEVATED TEMPERATURE; AREA WAS HOT TO TOUCH; AREA AROUND INJECTIONS SITE WAS SWOLLEN AS WELL ; VISIT TO REDICARE FACILITY ; DX WITH BRONCHITIS 10/23/09 LARGER AFFECTED AREA; WAS RED & HOT TO TOUCH; "AREA OF CELLULITIS WAS TRAVELING DOWN MY ARM"; PAINFUL TO MOVE AFFECTED ARM; ELEVATED TEMPERATURE; MOTRIN TAKEN (400 MG) EVERY 8 HOURS WITH MINIMAL RELIEF; SECOND VISIT TO REDICARE (DIFFERENT LOCATION) DX WAS "SECONDARY INFECTION" WAS GIVEN KEFLEX X 7 DAYS;  10/29/09 NO REDNESS NOTED; NO CURRENT DISCOMFORT; TEMPERATURE NORMAL;
Approximately 20 pox-type areas on chest, naval, axilla and back. Mother used Calamine lotion for itching.
approx 1hr p/vax red dots were noticed by the mom on child face;took child to pvt MD was told poss rxn to MMR 20SEP large red, raised whelps noted & was taken to pvt MD;given inj for itching;also had inc diarrhea, vomiting;
This spontaneous report was received from a physician refers to a 21 year old student. Information regarding patient's medical history, concurrent condition, drug reactions/allergies and concomitant therapy was not provided. Reporting physician stated that the patient received the first dose in the HPV vaccine series of GARDASIL (lot #/expiry date unspecified) on 19-JAN-2015 and the second dose on 17-NOV-2015. The patient received their third dose in the HPV series with GARDASIL 9 (lot # L024993, expiry date: 17-OCT-2017) on 02-FEB-2016. Physician reported that the second and third doses were given outside the recommended dosing schedule. No adverse effects were reported. Additional information has been requested.
I received my first shot on April 6th, 2021, and on April 18th, 2021 I experienced extreme numbness with slight pain in the fold and shoulder of my arm. I went to the ER and they took a cat scan of my neck and reported back that everything looked normal - the nurse said it was most likely Cervical Radiculopathy. Then the following morning around 11 AM, I experienced very intense burning in my chest starting on the right side, eventually moving to the left encompassing my entire upper chest. I also experienced a very bad migraine, which I am typically used to but this one was more of a pressure headache between my temples that I felt in my ears and jaw. I made the decision to go back to the ER and to a different one this time. The ER failed to administer a Covid-19 test and to take bloodwork - both faults that family and friends in the medical field have pointed out to me. The doctor there had me receive an IV, a chest X-Ray, and an EKG. The X-Ray and EKG were both normal. The doctor had ordered a Covid-19 test but the nurse forgot to administer it before my discharge. In my IV I received Benadryl and Reglan along with typical IV fluids. I was also given Pepcid and Mylanta. At the end of my visit, the doctor concluded that he thought it was my acid reflux acting up - gastroenteritis. I went home and continued to experience chest burning, tightness, occasional numbness/pains in my body, and very, very bad headaches. On top of that, I could barely swallow - it felt as if my throat was closing. I took Pepcid and Tums and neither really did anything. After seeing a Cardiologist this same week, they ordered an Echocardiogram and routine bloodwork (metabolic panel). I will also be following up with a GI, and I received a Covid-19 test today and am awaiting the results. It is possible I contracted Covid before my shot, but it is also possible that I am having a delayed reaction to my first vaccination as well. Who knows.
Patient is experiencing pain in her left arm after receiving a flu shot 10/1/19.  Rates pain 6/10, dull, constant and is aggravated with movements such as putting on a jacket and reaching across her body.  She is also experiencing joint stiffening in her (L) shoulder, most noticeable in the mornings.  Has applied hot/cold compresses, lidocaine patches, muscle relaxers and has taken ibuprofen heat without relief.
Patient was 11 years old and 3 months at time of vaccine No side effects was reported by parents.  Vaccine Error due to age
Information has been received from a sonographer concerning her daughter, who an on unspecified date was vaccinated with the first dose of GARDASIL. On the same day, the patient was nauseous and turned green and within a few minutes after vaccination had recovered. The patient sought unspecified medical attention. Additional information has been requested.
Delayed period 45 days; This is a spontaneous report from a non-contactable consumer (patient). A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), left arm, on 26May2021, at dose 2, single and dose 1 single (lot number, expiration date was not reported), on an unspecified date; both via an unspecified route of administration (at the age of 28-years-old) for covid-19 immunization from doctor's office/urgent care. Medical history included covid-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient was not tested with covid-19 after the vaccination. The patient experienced delayed period of 45 days on an unspecified date. No treatment was administered for the event. The outcome of the event was recovered on an unspecified date in 2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Shortly after the shot she felt her throat was feeling swollen; This is a spontaneous report from a contactable consumer (patient). An adult female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number: unknown), via an unspecified route of administration in Mar2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were unknown. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. In Mar2021, shortly after the shot the patient felt her throat was feeling swollen. The patient said she went back to the site where administered and spoke with medical staff and was okay. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Within 10 Minutes of receiving the vaccine (4pm)  mild itching began on my scalp. Within about 15 minutes my entire body was covered in hives and I was scratching uncontrollably.  I took 2 Claritin redi tabs (a total of 20mg) to counter act the hives and itching.  By 7pm the itching subsided but the hives were still there in a rash like pattern that lasted for 3 days. I developed a severe migraine that lasted 2days. a low grade fever and by 11pm vomiting took place followed by diarrhea the following morning. My heart rate and blood pressure was compromised with extreme dips. My lows were in the 99/80, and my highs were as bad as 177/99. I continue to have high blood pressure now.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 07-JUN-2016, the patient was vaccinated with improperly stored M-M-R II (lot number reported as L01248, expiration date 10-APR-2017, albumin status therapy type, dose and route of administration were not reported). Concomitant therapy was not reported. The temperature of excursion was 50F and the time frame was 6 hours. There was no previous temperature excursion. It was stated that it was due to a data logger. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Chills Fever Pain at injection site Headache Dizziness  Back pain Neck pain
fever; chills/Shivering; pelvic pain; nausea; headache; This is a spontaneous report from a contactable consumer.  A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on the left arm on 06Jan2021 15:15 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history was reported as none.  Concomitant medications were not reported. The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE (lot/batch number: not provided) via unknown route of administration on the left arm on 20Dec2020 16:15 at a single dose for COVID-19 immunization. On 07Jan2021 04:00, the patient had fever, chills/shivering, pelvic pain, headache, and nausea symptoms resolved next day (08Jan2021). Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The patient did not receive any treatment for the events.    Information about lot/batch number has been requested.
On 10-8-07 Hepatitis A and Menactra given. For 2 evenings after immunizations child developed fever to 102.5, stiffness and cramping of legs, malaise. Tylenol 500 mg q 4-6 hrs x 48 hrs given.
Incoherent-seizure. Vomiting. Unstable blood pressure. Husband took her to ER.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 1/10/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Dizziness.  Eventually took meclizine hcl 0.25 mg.
received a dose from a punctured vial after the 12 hour timeframe in the refrigerator; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose from a punctured vial after the 12 hour timeframe in the refrigerator) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose from a punctured vial after the 12 hour timeframe in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received a dose from a punctured vial after the 12 hour timeframe in the refrigerator) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported  No treatment medication was reported   This case was linked to MOD-2021-208074, MOD-2021-258552, MOD-2021-258572, MOD-2021-258587, MOD-2021-258599, MOD-2021-258615, MOD-2021-258632, MOD-2021-258644, MOD-2021-258672, MOD-2021-258682, MOD-2021-258689, MOD-2021-258691, MOD-2021-258693, MOD-2021-258697, MOD-2021-258699, MOD-2021-258700, MOD-2021-258702, MOD-2021-258703, MOD-2021-258704, MOD-2021-258706, MOD-2021-207548 (Patient Link).
Headache has gotten worse; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support. A contactable consumer reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 12Feb2021 as single dose for covid-19 immunisation. Medical history included ongoing headache. Concomitant medications were not reported. The patient reported that her headache has gotten worse on 12Feb2021. The patient took Zomig but wanted to take something else for the pain. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Shingles (herpes zoster) Lasted for 1 week from the time that it presented - I was treated with valtrex
Runny nose; Initial information received on 16-Nov-2021 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involves an unknown demographic patient who experienced runny nose (rhinorrhoea) after receiving INFLUENZA VACCINE.  Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious runny nose (rhinorrhoea) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "me too but noe got a runn ie nose."  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome reported as unknown for the event.  There will be no information available on batch number for this case.
Pt stated he needed to sit immediately after vaccine. As he sat down pt leaned back-started to fall backward. I grabbed the chair pulled him forward and as he came forward his eyes popped open. He regained consciousness. The total time 5 seconds. Pt. sat for about 30 minutes. Called parent to come & pick him up. Pt left pharmacy about 1:30pm.
This spontaneous report as received from a Registered Nurse refers to a 21 year old female patient. The nurse stated that after reviewing a patient's vaccination history, the patient only received 1 dose of VARIVAX (Merck), injection (dose and route not reported) administered on 23-AUG-2007. Patient was in the office and would be receiving the second dose of VARIVAX (Merck) on 12-AUG-2013. No adverse effect was reported. Additional information has been requested.
Reddened area approx. 3" in diameter,  warm to touch,  itchy.   SOB, dizziness,  intermittent nausea,  intermittent diarrhea.
The patient developed delayed reaction of swollen, itchy, hard circular area at the injection site.  She is experiencing little pain but has soreness.